Gabrielle Lakusta

Gabrielle grew up in the Lower Mainland of B.C. and has lived in Vancouver since 2011. She holds an Associate of Arts Degree from Langara College, and a Bachelors of Arts Major in Journalism from Kwantlen Polytechnic University. Now, she writes for INN focusing on Life Science Investing. Aside from work, Gabrielle enjoys travelling, and enjoying the outdoors—especially when hiking and cycling.

glakusta@resourceinvestingnews.com

Articles

Video Round-Up: Biotech Showcase Conference 2019

The Biotech Showcase this year took place in San Francisco and gave international and local guests an opportunity to meet.

January 30th, 2019

Medtronic Announces Positive Results from the Largest ENB Study to Aid in Lung Cancer Diagnosis

Medtronic (NYSE:MDT) today announced that the Journal of Thoracic Oncology has published 12-month results of the NAVIGATE study, the largest, prospective, multicenter trial evaluating...

January 30th, 2019

IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT NDA

IntelGenx (TSXV:IGX,OTCQX:IGXT) a leading oral drug delivery company, today announced that the U.S. Food and Drug Administration has performed a...

January 30th, 2019

ASLAN Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate Restructuring

ASLAN Pharmaceuticals (Nasdaq:ASLN,TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, today announced a strategic corporate restructuring...

January 30th, 2019

Inspire Medical Systems Announces FDA Approval of New Sensing Lead

Inspire Medical Systems (NYSE:INSP) a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions...

January 30th, 2019

GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease

Global Blood Therapeutics (NASDAQ:GBT) today announced that data from its Phase 1/2 study of voxelotor in patients with sickle cell...

January 30th, 2019

Align Technology Announces Record 2018 Financial Results

Align Technology (Nasdaq:ALGN) today reported financial results for the fourth quarter (Q4’18) and year ended December 31, 2018 (FY 2018)....

January 30th, 2019